Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Jul 31, 2020

Filed with the SEC on Sep 14, 2020 and accepted by EDGAR at Sep 14, 2020, 16:45 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-07-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-05-01 to 2020-07-31$9.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-05-01 to 2020-07-31$5.3mus-gaap:CostOfGoodsAndServicesSold
Research and development3 months2020-05-01 to 2020-07-31$1.6mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2020-05-01 to 2020-07-31$24.0kus-gaap:OperatingIncomeLoss
Income tax3 months2020-05-01 to 2020-07-31$13.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-05-01 to 2020-07-31$75.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2020-05-01 to 2020-07-31$0.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-05-01 to 2020-07-31$0.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-05-01 to 2020-07-3114,231,641 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2020-05-01 to 2020-07-31−$715.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2020-05-01 to 2020-07-31$718.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-07-31$6.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-07-31$12.3mus-gaap:AssetsCurrent
Total assetsAt period end2020-07-31$22.8mus-gaap:Assets
Current liabilitiesAt period end2020-07-31$11.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-07-31$17.3mus-gaap:Liabilities
Shareholders' equityAt period end2020-07-31$5.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-20-013559. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.